arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

FILANA THERAPEUTICS, INC.

FLNA

$0.45 ▼ -0.11 (-19.99%) at close

18 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

FILANA THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $21.7M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -101.3% ↘

FCF / Share $-0.68 ↗

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$41.12M

↑ +277.6% —

Net Income Profit after all expenses

$-90.97M

↓ -273.7% —

Operating Margin Operating profit as % of sales

76.3%

↑ +313.2% —

FCF / Share Free cash flow per share

$-0.68

↑ +73.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	277.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3370%)	-5.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-165%)	-31.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-496%)	-18.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-328%)	—	—
EPS Growth YoY (%)	-254.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	77.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-22.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	-14.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—
Net Income Growth YoY (%)	-273.7% Weak ↓ Weak Declining Year-over-year change in net income	75.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-27.5% Weak ↑ Weak Improving Year-over-year change in net income	-135.4% Weak → Weak Stable Year-over-year change in net income	-411.3% Weak ↓ Weak Declining Year-over-year change in net income	-36.8% Weak ↓ Weak Declining Year-over-year change in net income	29.4% Excellent ↑ Excellent Improving Year-over-year change in net income	45.0% Excellent ↑ Excellent Improving Year-over-year change in net income	19.8% Good ↑ Good Improving Year-over-year change in net income	-5.0% Weak Weak Year-over-year change in net income	-14.2% Weak Weak Year-over-year change in net income	N/M	N/M	-31.9% Weak ↑ Weak Improving Year-over-year change in net income	78.3% Excellent Excellent Year-over-year change in net income	-246.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	73.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-28.5% Weak Weak Year-over-year change in free cash flow	1.5% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	34.7% Excellent Excellent Compound annual revenue growth over 3 years	-19.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	76.3% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+409%)	-35.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-339%)	-30.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-304%)	-81.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-643%)	-32.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-319%)	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	30.3% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	76.7% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+539%)	-31.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-364%)	-22.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-290%)	-71.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-696%)	-16.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-241%)	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-2.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-71.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	4.81x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.62x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	4.24x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-101.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-76.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-97.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-63.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	65.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-80.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-69.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-110.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-77.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	62.6% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-13.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-122.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-915%)	-16.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-70.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-571%)	-33.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-323%)	-12.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-6.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-21.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-33.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-323%)	-122.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-919%)	-79.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-631%)	-48.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-421%)	-30.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-306%)	65.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+335%)	-26.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-275%)	-5.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-36.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-343%)	-3.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Net Debt (USD)	$-95.50M	$-128.57M	$-121.14M	$-201.01M	$-233.44M	$-93.51M	$-23.08M	$-19.81M	$-10.48M	$-16.61M	$-31.30M	$-40.59M	$-48.59M	$-49.35M	$-73.14M	$-4.80M	$-35.79M	$-153.16M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$6.39	$1.70	—	—	—	—
Basic EPS, GAAP (USD)	$-1.88	$-0.53	$-2.32	$-1.90	—	—	—	—	—	—	$-2.17	$-1.89	$4.90	$-0.56	—	—	—	—
Free Cash Flow per Share (USD)	$-0.68	$-2.53	$-1.97	$-2.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.54	$3.02	$3.25	$5.45	$6.35	$2.62	$1.01	$1.14	$1.47	$2.83	$4.49	$6.13	$7.43	$2.03	$6.94	$5.37	—	—
Tangible Book Value per Share (USD)	$1.54	$3.02	$3.25	$5.44	$6.32	$2.62	$1.01	$1.14	$1.47	$2.83	$4.49	$6.13	$7.43	$2.03	$6.94	$5.37	—	—
Basic Weighted Avg Shares (shares)	48.30M	46.33M	41.93M	40.20M	—	—	—	—	—	—	6.54M	6.47M	6.43M	6.40M	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$53.88M	$124.78M	$115.44M	$204.16M	$231.95M	$92.13M	$21.96M	$19.53M	$9.53M	$18.41M	$29.14M	$39.98M	$48.30M	$46.51M	$85.22M	$84.41M	—	—
Total Equity (USD)	$74.40M	$145.70M	$137.47M	$227.54M	$253.91M	$92.20M	$22.10M	$19.63M	$9.70M	$18.64M	$29.37M	$40.06M	$48.30M	$13.14M	$44.39M	$32.93M	$108.25M	$104.29M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$41.12M	$10.89M	$11.48M	$16.81M	$20.56M	—
Depreciation Expense (USD)	$903.00K	$952.00K	$1.08M	$804.00K	$310.00K	$22.00K	$58.00K	—	—	—	—	—	—	$122.00K	$163.00K	$232.00K	$257.00K	—
Net Income, GAAP (USD)	$-90.97M	$-24.34M	$-97.22M	$-76.25M	$-32.38M	$-6.33M	$-4.63M	$-6.56M	$-11.91M	$-14.85M	$-14.14M	$-12.39M	$31.54M	$-3.45M	$-2.61M	$-12.02M	$-3.47M	—
Operating Cash Flow (USD)	$-32.25M	$-116.93M	$-82.03M	$-77.51M	$-30.20M	$-5.38M	$-2.51M	$-4.77M	$-8.24M	$-12.23M	—	—	—	—	$-260.00K	$-143.00K	$-14.69M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 67 quarters

FILANA THERAPEUTICS, INC.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare FLNA with peers